Comparative study of the chitooligosaccharides effect on the proliferation inhibition and radiosensitization of three types of human gastric cancer cell line

被引:0
作者
Yang Luo [1 ]
Liang Deng [1 ]
Qiu-Ju Deng [2 ]
Li Wen [3 ]
机构
[1] Department of Gastroenterology, the First Affiliated Hospital of Chongqing Medical University
[2] Department of Cardiology, First Affiliated Hospital of Chongqing Medical University
[3] Department of Genetics, Beijing Cancer Hospital
关键词
Chitooligosaccharides; Gastric cancer; Radiotherapy; radiosensitization; Cell cycle; Apoptosis;
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
100214 ;
摘要
Objective:To observe the chitooligosaccharides(COS) effect on the proliferation inhibition and radiosensitivity of three types of human gastric cancer cell line.Mothods:CCK-8 assay was employed to obtain the inhibition ratio of COS on BGC823 cells,MKN45 cells and SGC7901 cells at 48 h after treatment and the proliferation-inhibition curve was drawn with the inhibition ratio of COS on three types of cells.The clonogenic assay was used to detect the cell viability of 0,1,2,4,6 and 8 Gy(6 dose grades) in RAY group and RAY+COS group after X-ray,and the cell survival curve was used to analyze the sensitization enhancement ratio of COS.Flow cytometry was employed to detect cell cycle and apoptosis rate in control group,RAY group and RAY+COS group after 48 h treatment.Results:COS inhibited the proliferation of three types of cells.The inhibition rate was positively correlated with the concentration of COS,and the susceptibility of MKN45 cells,SGC7901 cells and BGC823 cells to COS decreased in turn.The cell viability decreased gradually with the increasing radiation dose in RAY group and RAY+COS group(P<0.01).The cell viabilities of RAY+COS group were lower than those of RAY group at all the dose grades under X-ray exposure(P<0.01),and the sensitization enhancement ratios of COS on BGC823 cells,MKN45 cells and SGC7901 cells were 1.06,1.28 and 1.15 respectively.In controlled trials,apoptosis rate and percentage in the G/M phase of three types of cells in RAY+COS group were higher than those in control group and RAY group,and percentage in the S phase and the G/Gphase in RAY+COS group were lower than those in the other two groups(P<0.01).Conclusions:COS can inhibit the proliferation of three types of human gastric cancer cells and enhance the radiosensitivity by inducing apoptosis and G/M phase arrest.
引用
收藏
页码:581 / 585
页数:5
相关论文
共 14 条
[1]  
Treatment of gastric cancer[J]. Michele Orditura,Gennaro Galizia,Vincenzo Sforza,Valentina Gambardella,Alessio Fabozzi,Maria Maddalena Laterza,Francesca Andreozzi,Jole Ventriglia,Beatrice Savastano,Andrea Mabilia,Eva Lieto,Fortunato Ciardiello,Ferdinando De Vita.World Journal of Gastroenterology. 2014(07)
[2]   Annual report on status of cancer in China,2010 [J].
Wanqing Chen ;
Rongshou Zheng ;
Siwei Zhang ;
Ping Zhao ;
Hongmei Zeng ;
Xiaonong Zou ;
Jie He .
ChineseJournalofCancerResearch, 2014, 26 (01) :48-58
[3]  
Review article: the epidemiology and prevention of gastric cancer[J] . K. M. Fock.Aliment Pharmacol Ther . 2014 (3)
[4]   Chitooligosaccharides inhibit ethanol-induced oxidative stress via activation of Nrf2 and reduction of MAPK phosphorylation [J].
Luo, Zhiguo ;
Dong, Xiaoxia ;
Ke, Qing ;
Duan, Qiwen ;
Shen, Li .
ONCOLOGY REPORTS, 2014, 32 (05) :2215-2222
[5]  
Selective Targeting of the G2/M Cell Cycle Checkpoint to Improve the Therapeutic Index of Radiotherapy[J] . M.T. Dillon,J.S. Good,K.J. Harrington.Clinical Oncology . 2014
[6]  
Radiotherapy for gastric cancer: a systematic review and meta-analysis[J] . Xiaohui Pang,Wanqing Wei,Weibing Leng,Qi Chen,Hongwei Xia,Liu Chen,Ronghui Li.Tumor Biology . 2014 (1)
[7]  
Cdks, cyclins and CKIs: roles beyond cell cycle regulation[J] . Shuhui Lim,Philipp Kaldis.Development . 2013 (15)
[8]  
Conditional Probability of Survival Nomogram for 1-, 2-, and 3-Year Survivors After an R0 Resection for Gastric Cancer[J] . Johan L. Dikken,Raymond E. Baser,Mithat Gonen,Michael W. Kattan,Manish A. Shah,Marcel Verheij,Cornelis J. H. Velde,Murray F. Brennan,Daniel G. Coit.Annals of Surgical Oncology . 2013 (5)
[9]   Adjuvant IMRT/XELOX radiochemotherapy improves long-term overall- and disease-free survival in advanced gastric cancer [J].
Boda-Heggemann, J. ;
Weiss, C. ;
Schneider, V. ;
Hofheinz, R. -D. ;
Haneder, S. ;
Michaely, H. ;
Wertz, H. ;
Ronellenfitsch, U. ;
Hochhaus, A. ;
Wenz, F. ;
Lohr, F. .
STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (05) :417-423
[10]  
Gastric cancer epidemiology and risk factors[J] . Douglas E. Guggenheim,Manish A. Shah.J. Surg. Oncol. . 2012 (3)